LAUSR

Abstract Kyushu University Hospital has been designated as a Core Hospital for Cancer Genomic Medicine since February 2018. Our institution promotes cancer genomic medicine collaborating with 16 Cooperative Hospitals for Cancer Genomic Medicine among Kyushu, Chugoku, and Shikoku region. From November 2018 to March 2019, a total of 120 solid tumor cases has been examined by clinical sequencing tests and the results have been intensively evaluated and discussed in the expert panel meetings. One of the features of our institution is an employment of multiple clinical sequencing tests for different purposes and that the concordance of each test is assessed. In our institution, a cancer genomic outpatient, which enhanced genetic counseling division, has been started and a new hospital information system for cancer genomic medicine was developed. This hospital information system integrates the result of a cancer genome sequence report and physicians can refer to the progress and results of clinical sequencing test in real time. Current progress and issues of cancer genomic medicine in Kyushu University Hospital will be presented.